This resource, developed by the Network for Public Health Law and released on July 17, 2017, provides a brief overview of jurisdictions with statutory and regulatory provisions legalizing medical marijuana use. The survey compiles key information concerning legal provisions for medical marijuana in 29 states and the District of Columbia that have passed or enacted Comprehensive Medical Marijuana Programs. Eighteen states have adopted Limited Access Marijuana Product Laws permitting only low (or zero) Tetrahydrocannabinol (THC) and high Cannabidiol (CBD) products to treat several, often specified conditions, usually uncontrolled epilepsy disorders.
For more information about the document, go to https://www.networkforphl.org/resources_collection/2017/07/17/486/survey_medical_marijuana_programs/?utm_source=Network+Report+7-20-17&utm_campaign=Network+Report+7-20-17&utm_medium=email&utm_content=312.